Christiane E Angermann1, Georg Ertl2. 1. Department of Internal Medicine I and Comprehensive Heart Failure Center, University and University Hospital of Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. Angermann_C@ukw.de. 2. Department of Internal Medicine I and Comprehensive Heart Failure Center, University and University Hospital of Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany.
Abstract
PURPOSE OF REVIEW: Depression, anxiety, and cognitive impairment constitute established risk markers for incident cardiovascular disease (CVD) and are associated with impaired life expectancy and quality of life and high hospitalization rates and healthcare expenditure. This review summarizes current knowledge about mental health disorders in patients with CVD and heart failure (HF). RECENT FINDINGS: Emerging evidence suggests various shared pathophysiological mechanisms between psychological comorbidities and CVD (e.g., systemic inflammation and autonomic dysfunction). Bi-directional interactions involving the central nervous and cardiovascular systems may help explain the rising prevalence of comorbid mood disorders with increasing CVD severity and support the concept of alternative pathophysiological mechanisms in the presence of severe somatic illness, making symptoms less responsive or unresponsive to psychotropic pharmacotherapy. Considering high prevalence and negative impact of psychological comorbidities in CVD and HF, routine care should integrate screening for these conditions. Multidisciplinary treatment approaches with active patient participation in disease management were shown to improve outcomes. However, better understanding of factors mediating the adverse prognostic effects of mood disorders is needed. This might enable more targeted treatment and possibly also facilitate better understanding of the pathophysiological mechanisms driving CVD.
PURPOSE OF REVIEW: Depression, anxiety, and cognitive impairment constitute established risk markers for incident cardiovascular disease (CVD) and are associated with impaired life expectancy and quality of life and high hospitalization rates and healthcare expenditure. This review summarizes current knowledge about mental health disorders in patients with CVD and heart failure (HF). RECENT FINDINGS: Emerging evidence suggests various shared pathophysiological mechanisms between psychological comorbidities and CVD (e.g., systemic inflammation and autonomic dysfunction). Bi-directional interactions involving the central nervous and cardiovascular systems may help explain the rising prevalence of comorbid mood disorders with increasing CVD severity and support the concept of alternative pathophysiological mechanisms in the presence of severe somatic illness, making symptoms less responsive or unresponsive to psychotropic pharmacotherapy. Considering high prevalence and negative impact of psychological comorbidities in CVD and HF, routine care should integrate screening for these conditions. Multidisciplinary treatment approaches with active patient participation in disease management were shown to improve outcomes. However, better understanding of factors mediating the adverse prognostic effects of mood disorders is needed. This might enable more targeted treatment and possibly also facilitate better understanding of the pathophysiological mechanisms driving CVD.
Authors: François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin Journal: JAMA Date: 2007-01-24 Impact factor: 56.272
Authors: Steven L Sayers; Nancy Hanrahan; Ann Kutney; Sean P Clarke; Brendali F Reis; Barbara Riegel Journal: J Am Geriatr Soc Date: 2007-08-21 Impact factor: 5.562
Authors: S Susan Hedayati; L Parker Gregg; Thomas Carmody; Nishank Jain; Marisa Toups; A John Rush; Robert D Toto; Madhukar H Trivedi Journal: JAMA Date: 2017-11-21 Impact factor: 56.272
Authors: Jacqueline O'Toole; Han Woo; Nirupama Putcha; Christopher B Cooper; Prescott Woodruff; Richard E Kanner; Robert Paine; Russell P Bowler; Alejandro Comellas; Karin F Hoth; Jerry A Krishnan; Meilan Han; Mark Dransfield; Anand S Iyer; David Couper; Stephen P Peters; Gerard Criner; Victor Kim; R Graham Barr; Fernando J Martinez; Nadia N Hansel; Michelle N Eakin Journal: Ann Am Thorac Soc Date: 2022-02
Authors: Malindi van der Mheen; Marijke H van der Meulen; Susanna L den Boer; Dayenne J Schreutelkamp; Jan van der Ende; Pieter Fa de Nijs; Johannes Mpj Breur; Ronald B Tanke; Nico A Blom; Lukas Aj Rammeloo; Arend Dj Ten Harkel; Gideon J du Marchie Sarvaas; Elisabeth Mwj Utens; Michiel Dalinghaus Journal: Eur J Cardiovasc Nurs Date: 2019-09-25 Impact factor: 3.908
Authors: Mirjam Dieckelmann; Juliana J Petersen; Corina Güthlin; Felix Reinhardt; Jasper Plath; Klaus Jeitler; Thomas Semlitsch; Ferdinand M Gerlach; Andrea Siebenhofer Journal: BMJ Open Date: 2020-10-10 Impact factor: 2.692
Authors: Renate B Schnabel; Gert Hasenfuß; Sylvia Buchmann; Kai G Kahl; Stefanie Aeschbacher; Stefan Osswald; Christiane E Angermann Journal: Herz Date: 2021-02-05 Impact factor: 1.443
Authors: Brett R Curtis; Bruce L Rollman; Bea Herbeck Belnap; Kwonho Jeong; Lan Yu; Matthew E Harinstein; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-06-11 Impact factor: 3.612